Doug Gessl
Finanzdirektor/CFO bei Ception Therapeutics, Inc.
Profil
Doug Gessl is currently the Chief Financial Officer at Ception Therapeutics, Inc. Prior to this, he held positions as Principal at Tucker Anthony Sutro and Nesbitt Burns, Inc., Principal at JPMorgan Chase & Co., Vice President-Finance & Administration at Fulcrum Pharmaceuticals, Inc., Chief Operating & Financial Officer at Ceptaris Therapeutics, Inc., and Senior Vice President at Einhorn Associates, Inc. Gessl holds an MBA from The University of Chicago and an undergraduate degree from the University of Wisconsin.
Aktive Positionen von Doug Gessl
Unternehmen | Position | Beginn |
---|---|---|
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Doug Gessl
Unternehmen | Position | Ende |
---|---|---|
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Finanzdirektor/CFO | - |
JPMORGAN CHASE & CO. | Corporate Officer/Principal | - |
Nesbitt Burns, Inc. | Corporate Officer/Principal | - |
Tucker Anthony Sutro | Corporate Officer/Principal | - |
Einhorn Associates, Inc. | Corporate Officer/Principal | - |
Ausbildung von Doug Gessl
The University of Chicago | Masters Business Admin |
University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JPMORGAN CHASE & CO. | Finance |
Private Unternehmen | 6 |
---|---|
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
Fulcrum Pharmaceuticals, Inc. | Health Technology |
Einhorn Associates, Inc. | Finance |
Tucker Anthony Sutro | Finance |
Nesbitt Burns, Inc. | Finance |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |